Skip to main content
OpenTrials
Completed

NCT Number: NCT00733213

Depiction of Prostate Cancer Treatment Alternatives in Greece

A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.

* Target Group: Patients with locally advanced or metastatic prostate cancer. * The first 10 consecutive patients records that meet the entry criteria.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002.
  • Patients that received Hormonal therapy.

Exclusion criteria

  • Males that are aged less than 18 years

Treatment and study plan

Primary outcomes

  1. Percentage of patients treated by each treatment alternative.

    Time frame: Between 2002 - 2008

Secondary outcomes

  1. To depict sociodemographic characteristics and comorbidities.

    Time frame: Between 2002 - 2008

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start
2008
Study completion
2009
First posted
Aug 12, 2008
Registry last updated
Oct 14, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.